DNA RNA and Cells

08 Apr 2008 Bristol-Myers Squibb Selects Isis Drug Targeting PCSK9 as Development Candidate for Prevention and Treatment of Cardiovascular Disease
07 Apr 2008 Danish biotech company's restorative Alzheimer's product has successfully been implanted in patients
07 Apr 2008 Targeted Genetics Acquires Rights to siRNA Development Program in Huntington's Disease From Sirna Therapeutics
01 Apr 2008 Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
01 Apr 2008 Amorcyte Completes Phase I Trial of Stem Cell Therapy for Acute Myocardial Infarction
31 Mar 2008 Alnylam Presents Pre-clinical Data from Hypercholesterolemia, Liver Cancer, Ebola, and Progressive Multifocal Leukoencephalopathy (PML) Programs at RNAi Keystone Symposium
31 Mar 2008 Argos Therapeutics Presents Positive Phase 1 Safety Data for its Arcelis Platform in HIV at Keystone Symposia
28 Mar 2008 Vical Licensee AnGes MG Files NDA in Japan for Collategene Angiogenesis Product
20 Mar 2008 Pronai Therapeutics, Inc. cleared to begin Phase I clinical trials for the first DNA interference (DNAi (R)) therapeutic
19 Mar 2008 Cenix BioScience Signs Framework Research Agreement with AstraZeneca for RNAi-Based Drug Discovery
18 Mar 2008 Targeted Genetics Announces Completion of Dosing for the Phase 1/2 Clinical Trial of tgAAC94 for Inflammatory Arthritis
17 Mar 2008 Archemix Announces Initiation of Phase 2 Trial for Aptamer Product Candidate ARC1779 in Patients with TTP, a Rare, Life-Threatening Blood Disorder
14 Mar 2008 Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study
13 Mar 2008 AstraZeneca signs drug delivery collaboration
13 Mar 2008 Arrowhead Subsidiary, Calando Pharmaceuticals, Submits IND for Clinical Trial with Targeted, Nano-Delivered RNAi Therapeutic for Cancer
12 Mar 2008 Sirnaomics and GRL Establish Partnership for the Development of Two Multi-Targeted RNAi Therapeutics Products
12 Mar 2008 Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug
11 Mar 2008 Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
06 Mar 2008 Oncolys BioPharma and Medigen Biotechnology Enters Strategic Alliance and License Agreement to Develop and Commercialize Telomelysin(R)(OBP-301) for a Potential New Treatment for Solid Tumors
04 Mar 2008 Pluristem Submits Pre-IND Application in Germany to Initiate Clinical Trials of PLX-PAD for Peripheral Artery Disease
29 Feb 2008 Phase II Clinical Trial of ALN-RSV01 Demonstrates Statistically Significant Anti-Viral Efficacy with an Approximately 40% Reduction in RSV Infection Rate and 95% Increase in Infection-Free Subjects
28 Feb 2008 AVONTEC announce results of a multiple dose clinical proof of concept study with its drug candidate AVT-01 decoy ODN in asthmatic patients
26 Feb 2008 Prochymal(TM) Demonstrates Lasting Benefit in Heart Attack
25 Feb 2008 Harvest Technologies announces patient enrollment has begun for a clinical trial in India using autologous adult stem cells to treat patients with non-reconstructible Critical Limb Ischemia (CLI) due to Peripheral Arterial Occlusive Disease (PAOD)
15 Feb 2008 OncoGenex Reports Lead Drug Candidate OGX-011 Achieved Primary Endpoint in Phase 2 Trial with Second-Line Chemotherapy for Prostate Cancer

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up